Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate) Images

Generic Name: sodium oxybate

This medication has been identified as Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate). It is supplied by Jazz Pharmaceuticals plc.

Xyrem is used in the treatment of Idiopathic Hypersomnia; Narcolepsy; Cataplexy and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. There is no proven risk in humans during pregnancy. Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images of medication

Xyrem

Generic Name: sodium oxybate
Strength: 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate)
Availability: Prescription only
Drug Class: Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category: B - No proven risk in humans
CSA Schedule: 3 - Moderate abuse potential
Labeler / Supplier: Jazz Pharmaceuticals plc
National Drug Code (NDC): 68727-0100